Disease-Type-Aware Biological Intelligence Layers for Preventing Symptom Marker False Positives in Computational Drug Target Identification
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Three-layer biological intelligence system: disease-type-aware target classifier (9 gene families, 119+ genes, 6-step pipeline), tissue expression boolean gate (Human Protein Atlas), and known-target validator. Prevents symptom markers (GABA receptors, ion channels, inflammatory cytokines) from being promoted as drug targets in infectious diseases while preserving them for autoimmune/neurodegenerative contexts. Mean F₁ = 0.474, zero false positives across 7 diseases.
Fields of Study & Subjects
Computational Drug Discovery Methods
Bioinformatics and Genomic Networks
Biomedical Text Mining and Ontologies
Publication details
- Journal / source
- Zenodo (CERN European Organization for Nuclear Research)
- Publication date
- 31 March 2026
- Language
- EN
- Document type
- Preprint